doi: 10.1099/0022-1317-74-6-945.
Prophylactic and therapeutic vaccination against a mucosal papillomavirus
Affiliations
- PMID: 8389809
- DOI: 10.1099/0022-1317-74-6-945
Item in Clipboard
Prophylactic and therapeutic vaccination against a mucosal papillomavirus
J Gen Virol.
1993 Jun.
Erratum in
- J Gen Virol 1993 Sep;74(Pt 9):2038
Abstract
Papillomaviruses are ubiquitous DNA viruses affecting humans and animals and causing a variety of tumours of mucosal and cutaneous epithelia. Some of these lesions, particularly those affecting mucosal epithelia, can progress to squamous cell carcinomas. Prevention or cure of viral infection would ultimately lead to a decrease in the incidence of papillomavirus-associated cancers. Using recombinant proteins, we have developed prophylactic and therapeutic vaccines against bovine papillomavirus type 4, a mucosal papillomavirus implicated in cancer of the alimentary canal in cattle; similar possibilities exist for the human mucosal papillomaviruses.
Similar articles
-
Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4.Virology. 1995 Aug 1;211(1):204-8. doi: 10.1006/viro.1995.1392. Virology. 1995. PMID: 7544045
-
Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.Virology. 1996 May 1;219(1):37-44. doi: 10.1006/viro.1996.0220. Virology. 1996. PMID: 8623552
-
Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies.J Gen Virol. 1996 Jul;77 ( Pt 7):1577-83. doi: 10.1099/0022-1317-77-7-1577. J Gen Virol. 1996. PMID: 8758002
-
Vaccination against papillomavirus in cattle.Clin Dermatol. 1997 Mar-Apr;15(2):275-83. doi: 10.1016/s0738-081x(96)00165-4. Clin Dermatol. 1997. PMID: 9167911 Review. No abstract available.
-
Bovine papillomavirus and cancer.Vet J. 1997 Nov;154(3):175-88. doi: 10.1016/s1090-0233(97)80019-6. Vet J. 1997. PMID: 9414951 Review.
Cited by
-
Papillomavirus-like Particles in Equine Medicine.Viruses. 2023 Jan 25;15(2):345. doi: 10.3390/v15020345. Viruses. 2023. PMID: 36851559 Free PMC article. Review.
-
Development of therapeutic vaccines for the treatment of diseases.Mol Biomed. 2022 Dec 8;3(1):40. doi: 10.1186/s43556-022-00098-9. Mol Biomed. 2022. PMID: 36477638 Free PMC article. Review.
-
Anogenital-Associated Papillomaviruses in Animals: Focusing on Bos taurus Papillomaviruses.Pathogens. 2020 Nov 27;9(12):993. doi: 10.3390/pathogens9120993. Pathogens. 2020. PMID: 33260814 Free PMC article. Review.
-
Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases.Vaccines (Basel). 2020 Oct 1;8(4):568. doi: 10.3390/vaccines8040568. Vaccines (Basel). 2020. PMID: 33019516 Free PMC article. Review.
-
Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies.Clin Vaccine Immunol. 2015 Jul;22(7):806-16. doi: 10.1128/CVI.00799-14. Epub 2015 May 13. Clin Vaccine Immunol. 2015. PMID: 25972404 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
